Welcome to our dedicated page for Select Medical news (Ticker: SEM), a resource for investors and traders seeking the latest updates and insights on Select Medical stock.
Select Medical Holdings Corporation (NYSE: SEM) generates frequent news due to its role as one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States based on the number of facilities. Company announcements regularly highlight developments across its three reportable segments: the critical illness recovery hospital segment, the rehabilitation hospital segment, and the outpatient rehabilitation segment.
Investors following SEM news will see recurring coverage of quarterly and annual financial results, including segment-level performance for its hospital and outpatient rehabilitation operations. Earnings releases often discuss revenue trends, income from continuing operations, Adjusted EBITDA, and other financial metrics, along with commentary on factors such as reimbursement, labor costs, and regulatory considerations referenced in the company’s forward-looking statements.
News flow for Select Medical also includes updates on capital allocation and corporate structure. The company has issued press releases about cash dividend declarations, a common stock repurchase program authorized by its board of directors, and financing transactions such as amendments to its credit agreement and the issuance of senior notes used to refinance existing debt. These items appear in both press releases and related Form 8-K filings.
Governance and strategic items are another source of SEM headlines. Recent disclosures describe leadership changes, including the appointment of a new chief executive officer and related board and executive role transitions, as well as amendments and restatements of the company’s bylaws. In addition, Select Medical has reported a tax-free distribution of shares of Concentra Group Holdings Parent, Inc. to its stockholders and, more recently, a non-binding indication of interest from its Executive Chairman, Co-Founder and Director to acquire all outstanding shares of Select Medical for cash consideration within a stated range per share.
Operational news can feature joint venture and partnership activity. For example, Select Medical Corporation announced an agreement with Ballad Health to jointly operate a critical illness recovery hospital in Tennessee, with Select Medical as majority owner and managing partner and plans to relocate the facility within Ballad Health’s system following regulatory approval. For readers tracking SEM, the news stream offers insight into financial performance, capital structure, leadership, governance, and facility-level initiatives across its nationwide post-acute and rehabilitation platform.
Summary not available.
Summary not available.
Summary not available.
Select Medical (NYSE: SEM) agreed to be acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson and Welsh, Carson, Anderson & Stowe for $16.50 per share in cash, implying an enterprise value of $3.9 billion. The price represents ~18% and ~25% premiums to specified prior prices.
The Special Committee and disinterested directors unanimously approved the Merger Agreement. Certain insiders will roll approximately 11.8% of outstanding shares into the surviving parent. Closing is expected mid 2026, subject to shareholder and regulatory approvals; the company will deregister and go private upon completion.
Select Medical (NYSE: SEM) reported Q4 2025 revenue of $1,396.6M (+6.4%) and FY2025 revenue of $5,452.8M (+5.1%). Q4 income from continuing operations rose to $37.7M; FY income was $214.5M. Adjusted EBITDA was $104.7M (Q4) and $493.2M (FY). The board declared a $0.0625 per-share cash dividend payable ~March 12, 2026, and authorized a $1.0B repurchase program. The company issued 2026 outlook: revenue $5.6–5.8B, Adjusted EBITDA $520–540M, and EPS $1.22–1.32. A take-private proposal from Executive Chairman Robert Ortenzio is under Special Committee review.
Select Medical (NYSE:SEM) and the Philadelphia Eagles announced a multi-year extension renewing NovaCare Rehabilitation as the team's Official Physical Therapy Partner, continuing a 25-year founding partnership.
The agreement names NovaCare as a presenting sponsor for digital fan content, in-stadium signage and videoboards, radio spots, gameday notifications, and continued community involvement including the Eagles Autism Challenge.
Select Medical Holdings (NYSE: SEM) will release fourth quarter and full year results for the period ended December 31, 2025 on February 19, 2026 after market close and will host a business outlook conference call on February 20, 2026 at 9:00 AM ET.
The live webcast and replay are available via the company website; telephone participants may pre-register to receive dial-in numbers and a passcode. As of December 31, 2025, Select Medical operated 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across 39 states and the District of Columbia.
Select Medical (NYSE: SEM) will release fourth quarter and full year results for the period ended Dec 31, 2025 on Thursday, Feb 19, 2026 after market close. The company will host a live conference call and webcast on Friday, Feb 20, 2026 at 9:00 AM ET, with a replay available shortly after.
Select Medical operates a network of rehabilitation and recovery facilities: 104 critical illness recovery hospitals in 28 states, 38 rehabilitation hospitals in 15 states, and 1,917 outpatient rehabilitation clinics in 39 states and the District of Columbia as of Dec 31, 2025. Investor registration and webcast access are available via the company website.
Select Medical (NYSE: SEM) said it received a non-binding take-private indication of interest from Executive Chairman Robert A. Ortenzio to acquire all outstanding shares for $16.00 to $16.20 per share. Mr. Ortenzio announced the Proposal on November 24, 2025 via a Schedule 13D filing with the SEC.
The disinterested members of the board are reviewing the Proposal with advisors and said they are committed to acting in stockholders' best interests. The company cautioned there is no assurance the Proposal will result in any particular outcome and will not comment further unless additional disclosure is appropriate or required by law.
Select Medical (NYSE: SEM) reported Q3 2025 revenue $1,363.4M (+7.2% YoY) and Q3 Adjusted EBITDA $111.7M (+7.5% YoY). Income from continuing operations before other items rose to $73.0M (+32.9% YoY) and diluted EPS from continuing operations was $0.23 (+21.1% YoY). For the nine months, revenue was $4,056.2M (+4.7% YoY) and diluted EPS was $1.00 (+44.9% YoY).
The board declared a cash dividend of $0.0625 per share payable ~November 25, 2025, and extended a $1.0B share repurchase authorization to December 31, 2027. FY2025 guidance was updated to revenue $5.3B–$5.5B, Adjusted EBITDA $510M–$530M, and EPS $1.14–$1.24.